Clinical Trial Update: Rapid Antiretroviral Treatment Initiation With BIC/FTC/TAF in HIV-infected People Who Inject Drugs (PWID)

View source ↗

Summary

This completed clinical trial evaluates rapid initiation of the bictegravir/emtricitabine/tenofovir alafenamide regimen in HIV-infected people who inject drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIC/FTC/TAF (bictegravir/emtricitabine/tenofovir alafenamide) (bictegravir/emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases | Conditions: HIV Positive People Who Inject Drugs | Status: COMPLETED